SEREVENT - salmeterol xinafoate
Navigation: NDC > Supplier starting with: G > GLAXOSMITHKLINE LLC| Field | Value |
|---|---|
| NDC Code: | 0173-0521 |
| Proprietary Name: | SEREVENT |
| Suffix: | DISKUS |
| Non-Proprietary Name: | salmeterol xinafoate |
| Dosage Form: | POWDER, METERED |
| Method: | ORAL; RESPIRATORY (INHALATION) |
| Original Marketing Date: | 25-11-1997 |
| Category Name: | NDA |
| Application Number: | NDA020692 |
| Labeler: | GLAXOSMITHKLINE LLC |
| Substance Name: | SALMETEROL XINAFOATE |
| Active Numerator Strength: | 50 |
| Active Ingredient Unit: | ug/1 |
| Pharm Classes: | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| DEA Schedule: |